Clinical Trials Logo

Clinical Trial Summary

The syndrome of distractibility is a behavioral disorder induced by a lesion or a dysfunction of the frontal lobe. This sign is frequent in patients with progressive supranuclear palsy (PSP), a neurodegenerative disorder with severe neuronal loss in the prefrontal cortex and cholinergic systems, in particular in the Meynert basalis nucleus. This could participate in the occurrence of the distractibility in these patients. The aim of this study is to evaluate the effect of the donepezil, an anticholinesterase, on the distractibility in PSP patients, by using oculomotor and neuropsychological assessments.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00139373
Study type Interventional
Source Groupe Hospitalier Pitie-Salpetriere
Contact Bertrand Gaymard, MD, PhD
Phone 33-142162218
Email gaymard@ccr.jussieu.fr
Status Recruiting
Phase Phase 2

See also
  Status Clinical Trial Phase
Completed NCT00368199 - Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes N/A
Completed NCT02132052 - Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.
Completed NCT03076671 - More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease N/A
Terminated NCT03068468 - Study of BIIB092 in Participants With Progressive Supranuclear Palsy Phase 2
Recruiting NCT04468932 - Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy N/A
Completed NCT04858893 - Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms
Terminated NCT02658916 - Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003 Phase 1